Ubs Asset Management Americas Inc Procept Bio Robotics Corp Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 116,460 shares of PRCT stock, worth $8.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116,460
Previous 113,377
2.72%
Holding current value
$8.44 Million
Previous $6.93 Million
34.7%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PRCT
# of Institutions
272Shares Held
39.6MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$351 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$253 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$111 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$90.1 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$85.5 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.23B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...